ADC Therapeutics ADCT
NYSE ADCT
$1.60 +0.09 (+5.63%)
As of: Nov 11, 2026 · 3:59 PM EST

ADC Therapeutics (ADCT) EBIT (2019 - 2026)

Updated

ADC Therapeutics (ADCT) recorded EBIT of -$25.41 million in Q2 2026, compared with -$44.15 million a year earlier.

Analysis

ADC Therapeutics (ADCT) EBIT (2019 - 2026) Analysis & Trends

On a TTM basis, ADC Therapeutics' EBIT came in at -$125.78 million as of Jun 30, 2026.

  • Quarterly EBIT has ranged from -$69.41 million in Q2 2022 to -$3.11 million in Q3 2022 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.27 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.39 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.46 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.47 Bn
10 ADC Therapeutics 192.88 Mn -707.77 Mn 19.74 Mn -14.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -14.35 Mn
Jun 30, 2026 -25.41 Mn
Mar 31, 2026 -25.25 Mn
Dec 31, 2025 -17.92 Mn
Sep 30, 2025 -30.97 Mn
Jun 30, 2025 -44.15 Mn
Mar 31, 2025 -28.46 Mn
Dec 31, 2024 -32.44 Mn
Sep 30, 2024 -35.56 Mn
Jun 30, 2024 -29.04 Mn
Mar 31, 2024 -33.61 Mn
Dec 31, 2023 -39.98 Mn
Sep 30, 2023 -36.15 Mn
Jun 30, 2023 -39.65 Mn
Mar 31, 2023 -51.57 Mn
Dec 31, 2022 -10.74 Mn
Sep 30, 2022 -3.11 Mn
Jun 30, 2022 -69.41 Mn
Mar 31, 2022 -40.36 Mn
Dec 31, 2021 -62.78 Mn
API Access

ADC Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ADCT&period=max&api_key=YOUR_API_KEY